BR112012004080A2 - composições farmacêuticas para tratar ibd - Google Patents
composições farmacêuticas para tratar ibdInfo
- Publication number
- BR112012004080A2 BR112012004080A2 BR112012004080A BR112012004080A BR112012004080A2 BR 112012004080 A2 BR112012004080 A2 BR 112012004080A2 BR 112012004080 A BR112012004080 A BR 112012004080A BR 112012004080 A BR112012004080 A BR 112012004080A BR 112012004080 A2 BR112012004080 A2 BR 112012004080A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- treating ibd
- ibd
- treating
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09290645A EP2298321A1 (en) | 2009-08-26 | 2009-08-26 | Novel pharmaceutical compositions for treating IBD |
PCT/IB2010/053812 WO2011024122A1 (en) | 2009-08-26 | 2010-08-25 | Pharmaceutical compositions for treating ibd |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012004080A2 true BR112012004080A2 (pt) | 2016-03-08 |
Family
ID=41491565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012004080A BR112012004080A2 (pt) | 2009-08-26 | 2010-08-25 | composições farmacêuticas para tratar ibd |
Country Status (9)
Country | Link |
---|---|
US (1) | US9511019B2 (pt) |
EP (2) | EP2298321A1 (pt) |
JP (1) | JP5693581B2 (pt) |
CN (1) | CN102573852A (pt) |
AU (1) | AU2010288203B2 (pt) |
BR (1) | BR112012004080A2 (pt) |
CA (1) | CA2771871C (pt) |
RU (1) | RU2561040C2 (pt) |
WO (1) | WO2011024122A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
ATE251449T1 (de) | 1999-06-14 | 2003-10-15 | Cosmo Spa | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe |
ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
EP2396082B1 (en) | 2009-02-16 | 2013-07-31 | Nogra Pharma Limited | Methods for treating hair related conditions |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
RU2616500C2 (ru) | 2011-10-31 | 2017-04-17 | Новартис Аг | Композиция пазопаниба |
EA030762B1 (ru) | 2012-02-09 | 2018-09-28 | Ногра Фарма Лимитед | Способы лечения фиброза |
CA2864065A1 (en) * | 2012-02-13 | 2013-08-22 | Cosmo Technologies Limited | Method for treating intestinal diseases presenting at least one inflammatory component |
US9682050B2 (en) | 2012-04-18 | 2017-06-20 | Nogra Pharma Limited | Methods of treating lactose intolerance |
US20170000727A1 (en) * | 2013-12-20 | 2017-01-05 | Disphar International B.V. | Dry enema product |
WO2017046343A1 (en) * | 2015-09-17 | 2017-03-23 | Nogra Pharma Limited | Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same |
KR20210125047A (ko) | 2019-02-08 | 2021-10-15 | 노그라 파마 리미티드 | 3-(4'-아미노페닐)-2-메톡시프로피온산, 및 그의 유사체 및 중간체의 제조 방법 |
RU2752082C1 (ru) * | 2020-09-29 | 2021-07-22 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3134718A (en) | 1963-12-12 | 1964-05-26 | Schering Corp | Pregna-1,4-dienes and compositions containing same |
US5498608A (en) | 1994-01-07 | 1996-03-12 | Salix Pharmaceuticals | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
DE19849737A1 (de) * | 1998-10-28 | 2000-05-04 | Falk Pharma Gmbh | Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen |
JP2004534841A (ja) * | 2001-07-09 | 2004-11-18 | コンビナトアールエックス インコーポレーティッド | 炎症疾患の治療のための組合せ |
GB0203421D0 (en) | 2002-02-13 | 2002-04-03 | Alizyme Therapeutics Ltd | Composition |
CA2491355A1 (en) * | 2002-07-05 | 2004-01-15 | Temrel Limited | Controlled release compositions comprising coated pellets having non-uniform coating thicknesses |
GB0329851D0 (en) * | 2003-12-23 | 2004-01-28 | Temrel Inc | Process for producing particles for pharmaceutical compositions |
EP1810666A1 (en) * | 2006-01-19 | 2007-07-25 | Ferring International Center S.A. | Foam-Forming composition |
-
2009
- 2009-08-26 EP EP09290645A patent/EP2298321A1/en not_active Withdrawn
-
2010
- 2010-08-25 CA CA2771871A patent/CA2771871C/en not_active Expired - Fee Related
- 2010-08-25 RU RU2012106898/15A patent/RU2561040C2/ru not_active IP Right Cessation
- 2010-08-25 JP JP2012526166A patent/JP5693581B2/ja not_active Expired - Fee Related
- 2010-08-25 WO PCT/IB2010/053812 patent/WO2011024122A1/en active Application Filing
- 2010-08-25 BR BR112012004080A patent/BR112012004080A2/pt active Search and Examination
- 2010-08-25 EP EP10754586.5A patent/EP2470185B1/en active Active
- 2010-08-25 CN CN2010800388229A patent/CN102573852A/zh active Pending
- 2010-08-25 AU AU2010288203A patent/AU2010288203B2/en not_active Expired - Fee Related
- 2010-08-25 US US13/391,825 patent/US9511019B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2561040C2 (ru) | 2015-08-20 |
US9511019B2 (en) | 2016-12-06 |
EP2470185B1 (en) | 2016-11-16 |
US20120149667A1 (en) | 2012-06-14 |
EP2470185A1 (en) | 2012-07-04 |
AU2010288203B2 (en) | 2014-09-25 |
JP2013503150A (ja) | 2013-01-31 |
EP2298321A1 (en) | 2011-03-23 |
CA2771871A1 (en) | 2011-03-03 |
RU2012106898A (ru) | 2013-10-10 |
AU2010288203A1 (en) | 2012-03-15 |
CN102573852A (zh) | 2012-07-11 |
JP5693581B2 (ja) | 2015-04-01 |
CA2771871C (en) | 2015-05-26 |
WO2011024122A1 (en) | 2011-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201700008B (it) | Composizione farmaceutica | |
BR112012004080A2 (pt) | composições farmacêuticas para tratar ibd | |
SMT201600350B (it) | Composizioni farmaceutiche | |
SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
SMT201600307B (it) | Composizione liposomiale | |
BRPI0918971A2 (pt) | tienopirimidinas para composições farmacêuticas | |
DK3097925T3 (da) | Farmaceutisk sammensætning | |
DK2694038T3 (da) | Farmaceutisk sammensætning | |
BRPI1004940A2 (pt) | composição farmacêutica | |
BR112014003052A2 (pt) | composições farmacêuticas | |
DK3246018T3 (da) | Farmaceutisk sammensætning | |
BR112012031667A2 (pt) | composição | |
BRPI1013588A2 (pt) | composição | |
BRPI1012539A2 (pt) | composições farmacêuticas | |
BRPI1015939A2 (pt) | composição farmacêutica | |
BR112012032683A2 (pt) | composição | |
CO6930367A2 (es) | Composiciones farmaceúticas | |
BRPI1015474A2 (pt) | composição | |
EE201300005A (et) | Ravimkoostis | |
IT1394400B1 (it) | Composizioni farmaceutiche | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
BR112012032980A2 (pt) | composição | |
CO6801722A2 (es) | Composiciones farmacéuticas | |
BRPI1005318A2 (pt) | composição | |
BR112012003149A2 (pt) | composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2476 DE 19-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |